Ryan Specialty Holdings, Inc. (RYAN)
| Market Cap | 12.25B -28.7% |
| Revenue (ttm) | 3.10B +19.6% |
| Net Income | 108.69M +115.3% |
| EPS | 0.77 +187.1% |
| Shares Out | 263.66M |
| PE Ratio | 59.99 |
| Forward PE | 21.83 |
| Dividend | $0.52 (1.12%) |
| Ex-Dividend Date | May 12, 2026 |
| Volume | 3,093,540 |
| Open | 45.54 |
| Previous Close | 46.01 |
| Day's Range | 45.07 - 46.82 |
| 52-Week Range | 29.28 - 65.45 |
| Beta | 0.60 |
| Analysts | Buy |
| Price Target | 45.88 (-1.29%) |
| Earnings Date | Jul 30, 2026 |
About RYAN
Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, rest of Europe, India, Singapore, and internationally. The company offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter or a program administrator with delegated authority from insurance carriers. It serves commercial, industrial, institutional, indivi... [Read more]
Financial Performance
In 2025, Ryan Specialty Holdings's revenue was $2.99 billion, an increase of 21.95% compared to the previous year's $2.46 billion. Earnings were $63.40 million, a decrease of -33.03%.
Financial StatementsAnalyst Summary
According to 19 analysts, the average rating for RYAN stock is "Buy." The 12-month stock price target is $45.88, which is a decrease of -1.29% from the latest price.
News
Ryan Specialty price target raised to $69 from $68 at BofA
BofA raised the firm’s price target on Ryan Specialty (RYAN) to $69 from $68 and keeps a Buy rating on the shares. Q2 featured several notable catastrophe events globally, including…
Ryan Specialty price target raised to $44 from $40 at Piper Sandler
Piper Sandler raised the firm’s price target on Ryan Specialty (RYAN) to $44 from $40 and keeps a Neutral rating on the shares. The firm adjusted ratings and target in…
Ryan Specialty price target raised to $39 from $37 at JPMorgan
JPMorgan raised the firm’s price target on Ryan Specialty (RYAN) to $39 from $37 and keeps an Underweight rating on the shares. The firm adjusted targets in the insurance broker…
Ryan Specialty price target raised to $34 from $33 at Cantor Fitzgerald
Cantor Fitzgerald raised the firm’s price target on Ryan Specialty (RYAN) to $34 from $33 and keeps a Neutral rating on the shares. The firm updated its model for the…
Ryan Specialty price target raised to $39 from $35 at Mizuho
Mizuho analyst Yaron Kinar raised the firm’s price target on Ryan Specialty (RYAN) to $39 from $35 and keeps a Neutral rating on the shares.
Ryan Specialty price target lowered to $50 from $52 at UBS
UBS lowered the firm’s price target on Ryan Specialty (RYAN) to $50 from $52.
Ryan Specialty price target raised to $48 from $44 at Keefe Bruyette
Keefe Bruyette analyst Meyer Shields raised the firm’s price target on Ryan Specialty (RYAN) to $48 from $44 and keeps an Outperform rating on the shares.
Ryan Specialty price target raised to $46 from $39 at Barclays
Barclays raised the firm’s price target on Ryan Specialty (RYAN) to $46 from $39 and keeps an Overweight rating on the shares.
Ryan Specialty price target raised to $42 from $39 at Morgan Stanley
Morgan Stanley analyst Bob Huang raised the firm’s price target on Ryan Specialty (RYAN) to $42 from $39 and keeps an Overweight rating on the shares. Heading into earnings, property…
Ryan Specialty Underwriting Managers Completes a Series of Lloyd's Consortium Stamps to Support its Delegated Portfolio
CHICAGO--(BUSINESS WIRE)--Ryan Specialty Underwriting Managers (“RSUM”), the underwriting management division of Ryan Specialty (NYSE: RYAN), is pleased to announce the completion of a series of Lloyd...
Ryan Specialty to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026
CHICAGO--(BUSINESS WIRE)--Ryan Specialty Holdings, Inc. (NYSE: RYAN) (“Ryan Specialty”), a leading international specialty insurance firm, today announced it will release its Second Quarter 2026 finan...
Ryan Specialty price target raised to $40 from $35 at Goldman Sachs
Goldman Sachs raised the firm’s price target on Ryan Specialty (RYAN) to $40 from $35 and keeps a Neutral rating on the shares. Property and casualty insurers and brokers are…
Ryan Turner Specialty announce planned leadership succession
Ryan Turner Specialty, a leading wholesale distributor of specialty insurance products and services and the wholesale broking specialty of Ryan Specialty (RYAN), is pleased to announce a planned leade...
RT Specialty Announces Planned Leadership Succession
CHICAGO--(BUSINESS WIRE)--Ryan Turner Specialty ("RT Specialty"), a leading wholesale distributor of specialty insurance products and services and the wholesale broking specialty of Ryan Specialty (NY...
Ryan Specialty price target raised to $52 from $51 at UBS
UBS analyst Brian Meredith raised the firm’s price target on Ryan Specialty (RYAN) to $52 from $51 and keeps a Buy rating on the shares.
Ryan Specialty downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs downgraded Ryan Specialty (RYAN) to Neutral from Buy with a price target of $35, down from $42. The firm says its updated view for a prolonged period of…
AM Best Assigns Performance Assessment to Ryan Specialty (Singapore) Pte. Limited; Affirms Performance Assessment of Remaining Ryan Specialty Underwriting Managers' Affiliates
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned a Performance Assessment (assessment) of PA-1 (Exceptional) to Ryan Specialty (Singapore) Pte. Limited (Singapore). The outlook assign...
Ryan Specialty Holdings Transcript: 46th Annual William Blair Growth Stock Conference
A leading specialty insurance distributor leverages scale, talent, and innovation to drive growth, maintain resilience, and expand into new markets. Strong capital management and disciplined underwriting support a positive long-term outlook, even as market cycles evolve.
Ryan Specialty to Participate in the William Blair Growth Stock Conference
CHICAGO--(BUSINESS WIRE)--Ryan Specialty Holdings, Inc. (NYSE: RYAN) (“Ryan Specialty”), a leading international specialty insurance services firm, today announced that it will be presenting at the Wi...
Ryan Specialty price target raised to $44 from $42 at Keefe Bruyette
Keefe Bruyette raised the firm’s price target on Ryan Specialty (RYAN) to $44 from $42 and keeps an Outperform rating on the shares. Ryan Specialty announced a $300M increase to…
Ryan Specialty announces $300M increase to share repurchase program
Ryan Specialty (RYAN) Holdings announced that its Board of Directors on May 21, 2026 increased the authorization of its existing share repurchase program for shares of the Company’s Class A…
Ryan Specialty Announces $300 Million Increase to Share Repurchase Program
CHICAGO--(BUSINESS WIRE)--Ryan Specialty Holdings, Inc. (NYSE: RYAN) (“Ryan Specialty”), a leading international specialty insurance services firm, today announced that its Board of Directors on May 2...
Ryan Specialty price target lowered to $39 from $45 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Ryan Specialty (RYAN) to $39 from $45 and keeps an Overweight rating on the shares. Most property and casualty insurance companies saw…
Ryan Specialty price target lowered to $45 from $50 at Morgan Stanley
Morgan Stanley analyst Bob Huang lowered the firm’s price target on Ryan Specialty (RYAN) to $45 from $50 and keeps an Overweight rating on the shares.
Ryan Specialty Holdings, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Ryan Specialty Holdings, Inc. (NYSE: RYAN). The investigation focuses on Ry...